

![]() |
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study |
|
Authors | ![]() | |
Collaboration | With : Ozsahin, Ayse Hulya | |
Published in | Lancet oncology. 2013, vol. 14, no. 9, p. 834-42 | |
Abstract | The objective of this study was to establish the efficacy and safety of a new treatment regimen consisting of dose-dense cisplatin-based chemotherapy and radical surgery in children with high-risk hepatoblastoma. | |
Keywords | Adolescent — Antineoplastic Combined Chemotherapy Protocols/therapeutic use — Child — Child, Preschool — Cisplatin/administration & dosage — Combined Modality Therapy — Dose-Response Relationship, Drug — Doxorubicin/administration & dosage — Feasibility Studies — Female — Follow-Up Studies — Hepatectomy — Hepatoblastoma/mortality/pathology/therapy — Humans — Liver Neoplasms/mortality/pathology/therapy — Lung Neoplasms/mortality/secondary/therapy — Male — Prognosis — Prospective Studies — Survival Rate | |
Identifiers | PMID: 23831416 | |
Full text | ||
Structures | ||
Research group | Oncologie et hématologie pédiatrique (907) | |
Citation (ISO format) | ZSIROS, József et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. In: Lancet oncology, 2013, vol. 14, n° 9, p. 834-42. doi: 10.1016/S1470-2045(13)70272-9 https://archive-ouverte.unige.ch/unige:44657 |